McKesson Corporation (0JZU.L)
USD 570.25
(1.91%)
USD 570.25
(1.91%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 67.44 Billion USD | 8.22% |
| 2022 | 62.32 Billion USD | -1.55% |
| 2021 | 63.29 Billion USD | -2.64% |
| 2020 | 65.01 Billion USD | 6.15% |
| 2019 | 61.24 Billion USD | 2.64% |
| 2018 | 59.67 Billion USD | -1.17% |
| 2017 | 60.38 Billion USD | -0.96% |
| 2016 | 60.96 Billion USD | 7.87% |
| 2015 | 56.52 Billion USD | 4.92% |
| 2014 | 53.87 Billion USD | 4.08% |
| 2013 | 51.75 Billion USD | 48.79% |
| 2012 | 34.78 Billion USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 71.67 Billion USD | 6.27% |
| 2023 Q1 | 64.09 Billion USD | 2.85% |
| 2023 Q4 | 67.44 Billion USD | 1.4% |
| 2023 Q3 | 66.51 Billion USD | 0.64% |
| 2023 Q2 | 66.09 Billion USD | 3.11% |
| 2023 FY | 67.44 Billion USD | 8.22% |
| 2022 FY | 62.32 Billion USD | -1.55% |
| 2022 Q3 | 62.69 Billion USD | -0.62% |
| 2022 Q2 | 63.08 Billion USD | 1.26% |
| 2022 Q1 | 62.29 Billion USD | -1.58% |
| 2022 Q4 | 62.32 Billion USD | -0.59% |
| 2021 Q2 | 63.6 Billion USD | 1.12% |
| 2021 Q1 | 62.89 Billion USD | -3.26% |
| 2021 FY | 63.29 Billion USD | -2.64% |
| 2021 Q3 | 63.7 Billion USD | 0.17% |
| 2021 Q4 | 63.29 Billion USD | -0.64% |
| 2020 Q2 | 61.55 Billion USD | 6.75% |
| 2020 Q3 | 61.84 Billion USD | 0.47% |
| 2020 Q4 | 65.01 Billion USD | 5.13% |
| 2020 FY | 65.01 Billion USD | 6.15% |
| 2020 Q1 | 57.66 Billion USD | -5.85% |
| 2019 FY | 61.24 Billion USD | 2.64% |
| 2019 Q3 | 60.87 Billion USD | 3.19% |
| 2019 Q4 | 61.24 Billion USD | 0.61% |
| 2019 Q1 | 61.68 Billion USD | 3.37% |
| 2019 Q2 | 58.99 Billion USD | -4.35% |
| 2018 Q3 | 61.01 Billion USD | -0.67% |
| 2018 FY | 59.67 Billion USD | -1.17% |
| 2018 Q1 | 61.28 Billion USD | 1.49% |
| 2018 Q2 | 61.42 Billion USD | 0.23% |
| 2018 Q4 | 59.67 Billion USD | -2.19% |
| 2017 Q3 | 64.21 Billion USD | 0.57% |
| 2017 Q4 | 60.38 Billion USD | -5.97% |
| 2017 FY | 60.38 Billion USD | -0.96% |
| 2017 Q1 | 61.81 Billion USD | 1.39% |
| 2017 Q2 | 63.84 Billion USD | 3.28% |
| 2016 Q1 | 57.9 Billion USD | 2.44% |
| 2016 Q4 | 60.96 Billion USD | 5.35% |
| 2016 Q3 | 57.87 Billion USD | -0.76% |
| 2016 FY | 60.96 Billion USD | 7.87% |
| 2016 Q2 | 58.31 Billion USD | 0.71% |
| 2015 FY | 56.52 Billion USD | 4.92% |
| 2015 Q4 | 56.52 Billion USD | 2.61% |
| 2015 Q3 | 55.08 Billion USD | -1.31% |
| 2015 Q2 | 55.81 Billion USD | -0.19% |
| 2015 Q1 | 55.92 Billion USD | 3.81% |
| 2014 Q1 | 53 Billion USD | 2.41% |
| 2014 Q4 | 53.87 Billion USD | -2.25% |
| 2014 Q3 | 55.11 Billion USD | 5.51% |
| 2014 Q2 | 52.23 Billion USD | -1.46% |
| 2014 FY | 53.87 Billion USD | 4.08% |
| 2013 Q1 | 35.49 Billion USD | 2.03% |
| 2013 Q2 | 35.94 Billion USD | 1.28% |
| 2013 Q3 | 36.47 Billion USD | 1.48% |
| 2013 Q4 | 51.75 Billion USD | 41.89% |
| 2013 FY | 51.75 Billion USD | 48.79% |
| 2012 Q4 | 34.78 Billion USD | 4.05% |
| 2012 Q3 | 33.43 Billion USD | 0.0% |
| 2012 FY | 34.78 Billion USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Phreesia, Inc. | 371.08 Million USD | -18074.542% |
| Accuray Incorporated | 468.62 Million USD | -14291.616% |
| Align Technology, Inc. | 6.08 Billion USD | -1008.553% |
| Elevance Health Inc. | 108.92 Billion USD | 38.085% |
| AxoGen, Inc. | 196.82 Million USD | -34165.116% |
| Boston Scientific Corporation | 35.13 Billion USD | -91.948% |
| CVS Health Corporation | 249.72 Billion USD | 72.993% |
| Cardinal Health, Inc. | 45.12 Billion USD | -49.471% |
| Centene Corporation | 84.64 Billion USD | 20.319% |
| DaVita Inc. | 17.61 Billion USD | -282.775% |
| HCA Healthcare, Inc. | 56.21 Billion USD | -19.982% |
| Hologic, Inc. | 9.15 Billion USD | -636.599% |
| Humana Inc. | 47.06 Billion USD | -43.298% |
| IDEXX Laboratories, Inc. | 3.25 Billion USD | -1968.851% |
| Laboratory Corporation of America Holdings | 16.72 Billion USD | -303.244% |
| Masimo Corporation | 3.04 Billion USD | -2117.426% |
| Patterson Companies, Inc. | 2.96 Billion USD | -2171.525% |
| Quest Diagnostics Incorporated | 14.02 Billion USD | -380.98% |
| ResMed Inc. | 6.87 Billion USD | -881.361% |
| Henry Schein, Inc. | 10.57 Billion USD | -537.88% |
| Teladoc Health, Inc. | 4.39 Billion USD | -1435.458% |
| Universal Health Services, Inc. | 14.35 Billion USD | -369.762% |
| Veeva Systems Inc. | 5.91 Billion USD | -1040.99% |
| Baxter International Inc. | 28.27 Billion USD | -138.517% |
| Becton, Dickinson and Company | 52.78 Billion USD | -27.781% |
| Intuitive Surgical, Inc. | 15.44 Billion USD | -336.765% |
| Danaher Corporation | 84.48 Billion USD | 20.174% |
| Stryker Corporation | 39.91 Billion USD | -68.979% |
| Medtronic plc | 89.98 Billion USD | 25.048% |